[1] |
ZHANG Yan, CHEN Tongzhen, ZHU Xiaoli, LI Xiaoqiu.
Analysis of clinicopathological features of human papilloma virus-associated oropharyngeal squamous cell carcinoma
[J]. China Oncology, 2022, 32(1): 47-53.
|
[2] |
ZHANG Chi, CHEN Jiahui, LIN Jinyi, WANG Yan, ZHANG Sijia, ZHU Wei, CHENG Leilei.
Validation of a scale for evaluating the cardiovascular risk after breast cancer therapy: the clinical scale for breast cancer treatment related cardiovascular toxicity
[J]. China Oncology, 2022, 32(1): 54-60.
|
[3] |
JIN Yizi, LIN Mingxi, ZHANG Jian.
Targeting DNA damage response deficiency in the treatment of breast cancer
[J]. China Oncology, 2022, 32(1): 61-67.
|
[4] |
Expert group of expert consensus on neoadjuvant treatment of breast cancer in China (2021 edition) .
Expert consensus on neoadjuvant treatment of breast cancer in China (2021 edition)
[J]. China Oncology, 2022, 32(1): 80-89.
|
[5] |
ZHANG Xiaoyan , LI Qingxiang , LIU Yong , LI Hang , QIU Lijuan , FENG Xinran , TAN Liming .
A study on the correlation between HMGB1 and clinical characteristics and immune function in patients with breast cancer
[J]. China Oncology, 2021, 31(9): 783-788.
|
[6] |
XU Ran , WANG Xinyue , FENG Linyuan , HAN Anna , WANG Yixuan , YANG Wanshan , LIU Chao .
Expression and biological significance of NCAPD2 in glioma
[J]. China Oncology, 2021, 31(9): 789-798.
|
[7] |
CAO Ailing, CAO Zhe, ZHOU Jian.
Effects of docetaxel combined with thymosin α1 on number of Treg in immune microenvironment of rats with breast cancer and its mechanism
[J]. China Oncology, 2021, 31(9): 799-806.
|
[8] |
YAO Jia , LI Guanqiao , YANG Shiping , SU Huiluan .
Effect of hsa-miR-98-5p/DKK3 signal axis on biological behavior of breast cancer cells
[J]. China Oncology, 2021, 31(9): 807-816.
|
[9] |
LU Li, LU Renquan, SUN Jiajun, LU Ning, GUO Lin.
The application of serum N-MID in auxiliary diagnosis and therapeutic effect monitoring of bone metastasis in patients with primary lung cancer
[J]. China Oncology, 2021, 31(9): 838-844.
|
[10] |
Tumor Support and Rehabilitation Therapy Group, the Oncology Committee of Chinese Medical Association.
Clinical practice guidelines for cancer-related fatigue in China (2021 edition)
[J]. China Oncology, 2021, 31(9): 852-872.
|
[11] |
CONG Binbin, WANG Yongsheng.
Treatment landscape and challenges of managing the hormone receptor-positive early breast cancer
[J]. China Oncology, 2021, 31(8): 689-696.
|
[12] |
ZHU Yihui, LI Ting, HU Xichun.
Clinical research progress and prospect of trastuzumab deruxtecan
[J]. China Oncology, 2021, 31(8): 754-761.
|
[13] |
DING Gaofeng, GUO Leiming, LU Yufei.
The relationship between expressions of HER2 and BRCA1 and radiotherapy sensitivity in breast cancer patients
[J]. China Oncology, 2021, 31(7): 589-595.
|
[14] |
JIN Youping, LI Luying, ZHOU Ping.
A study on the role of long non-coding RNA STMN1P2 in breast cancer and its mechanism
[J]. China Oncology, 2021, 31(7): 596-604.
|
[15] |
XIE Jinfang , CAO Chunyu , REN Xue , TIAN Jiajun , LÜ Yafeng , HUANG Xiaofei .
Effects of sulforaphane on epithelial-mesenchymal transition, proliferation and migration of mouse breast cancer 4T1 cells
[J]. China Oncology, 2021, 31(7): 605-615.
|